Assessing claims of causation

Clinical Epidemiology: How to Do Clinical Practice Research: Third Edition

Volumn , Issue , 2012, Pages 356-386

  Tugwell, Peter ^a   Brian Haynes, R ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84975743659     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (29)

1. Diamond BA, Hulka BS, Kerkvliet NL, et al. Silicone breast implants in relation to connective tissue diseases and immunoloic dysfunction: a report by a National Science Panel to the Honorable Sam C. Pointer, Jr., coordinating judge for the federal breast implant multi-district litigation. Birmingham: Federal Judicial Center, November 1998.
2. Hill AB. Principles of medical statistics, 9th ed. London: Lancet, 1971.
3. Frye v. United States. 54 App. D.C. 46, 293 F. 1013. 1923.
4. Daubert, et al. v. Merrell Dow Pharmaceuticals. 92-102 June 28 1993, 113 S Ct 2768.
5. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20(1):47-63.
6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288(3):321-333.
7. Hulley S, Grady D, Bush T, et al. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280(7):605-613.
8. Nelson HD, Humphrey LL, Nygren P, et al. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;288:872-881.
9. Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002;137(4):273-284.
10. Bombardier C, Laine L, Reicin A, et al. VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343(21):1520-1528.
11. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003;361(9374):2017-2023.
12. Hemminki E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ 1997;315:149-153.
13. Sanchez-Guerrero J, Colditz GA, Karlson EW, et al. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 1995;332(25):1666-1670.
14. Hennekens CH, Lee IM, Cook NR, et al. Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA 1996;275(8):616-621.
15. Hulley SB, Cummings SR, Browner WS, et al. Designing clinical research. An epidemiologic approach, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001.
16. Feinstein AR. The architecture of clinical research. Philadelphia, PA: WB Saunders, 1985.
17. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994;309(6959):901-911.
18. Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of prospective study with implications regarding prevention. Arch Intern Med 1998;158:862-867; High homocysteine levels were associated with increased CHD in men, Abstract of ACP J Club 1998;129:51.
19. Fox R. The suicide drop-why? R Soc Health J 1975;95:9-13, 20.
20. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56(1):111-128.
21. Silverman S, Borenstein D, Solomon G, et al. Preliminary operational criteria for systemic silicone related disease (SSRD). Arthritis Rheum 1996;39(Suppl. 9):S51.
22. Sackett DK. Bias in analytic research. J Chronic Dis 1979;32:51-63.
23. The Newcastle-Ottawa Scale (NOS). Assessing the quality of non-randomized studies in meta-analysis. Presented to: The 3rd Symposium on Systematic Reviews: Beyond the Basics-Improving Quality and Impact, St. Catherine's College, Oxford, Jul. 2000.
24. Tugwell P, Wells G, Peterson J, et al. Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum 2001;44:2477-2484.
25. Sturrock RD, Batchelor JR, Harpwood V, et al. Silicone gel breast implants: the report of the independent review group. Cambridge, MA: Jill Rogers Associates, 1998.
26. Bondurant S, Ernster V, Herdman R, eds. Safety of silicone breast implants. Washington, DC: National Academy Press, 1999.
27. Hulka BS, Kerkvliet NL, Tugwell P. Experience of a scientific panel formed to advise the federal judiciary on silicone breast implants. N Engl J Med 2000;342(11):812-815.
28. Berger MA. Procedural paradigms for applying the Daubert test. Minn Law Rev 1994;78:1345-1348.
29. Kaiser J. Project offers judges neutral science advice. Science 1999;284:1600.